Striatal neuroprotection from neonatal hypoxia-ischemia in piglets by antioxidant treatment with EUK-134 or edaravone

Developmental Neuroscience

Volumn 33, Issue 3-4, 2011, Pages 299-311

  Ni, Xinli ^a   Yang, Zeng Jin ^a   Carter, Erin L ^a   Martin, Lee J ^b,c   Koehler, Raymond C ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b Division of Neuropathology   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

8 Nitroguanosine; Asphyxia; Cardiopulmonary resuscitation; Free radical scavenger; MCI 186; Nitrotyrosine; Oxidative stress; Superoxide dismutase

Indexed keywords

3 NITROTYROSINE; ANTIOXIDANT; CARBONYL DERIVATIVE; GLUCOSE; MANGANESE N,N' ETHYLENEBIS(3 METHOXYSALICYLIDENEAMINE); NORPHENAZONE; TYROSINE; UNCLASSIFIED DRUG;

AIRWAY OBSTRUCTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL PRESSURE; ARTICLE; ASPHYXIA; BLOOD GAS; BRAIN NERVE CELL; CAUDATE NUCLEUS; CELL DENSITY; CELL VIABILITY; CONTROLLED STUDY; CORPUS STRIATUM; CYTOPATHOLOGY; GLUCOSE BLOOD LEVEL; HISTOPATHOLOGY; HYPOXIA; IMMUNOHISTOCHEMISTRY; ISCHEMIA; MORBIDITY; MORTALITY; NEUROLOGIC DISEASE; NEUROPROTECTION; NITRATION; NITROSATIVE STRESS; NONHUMAN; OXIDATIVE STRESS; OXYGEN SATURATION; PIGLET; PRIORITY JOURNAL; RECTUM TEMPERATURE; RESUSCITATION; SCORING SYSTEM;

ANIMALS; ANIMALS, NEWBORN; ANTIOXIDANTS; ANTIPYRINE; CORPUS STRIATUM; FREE RADICAL SCAVENGERS; HYPOXIA-ISCHEMIA, BRAIN; NERVE DEGENERATION; NEUROPROTECTIVE AGENTS; ORGANOMETALLIC COMPOUNDS; OXIDATIVE STRESS; SALICYLATES; SWINE;

EID: 80255133262     PISSN: 03785866     EISSN: 14219859     Source Type: Journal    
DOI: 10.1159/000327243     Document Type: Article

References (55)

1. Ferriero DM: Neonatal brain injury. N Engl J Med 2004; 351: 1985-1995.
2. Gonzalez FF, Ferriero DM: Therapeutics for neonatal brain injury. Pharmacol Ther 2008; 120: 43-53.
3. Ferriero DM: Oxidant mechanisms in neonatal hypoxia-ischemia. Dev Neurosci 2001; 23: 198-202. (Pubitemid 34701672)
4. Lafemina MJ, Sheldon RA, Ferriero DM: Acute hypoxia-ischemia results in hydrogen peroxide accumulation in neonatal but not adult mouse brain. Pediatr Res 2006; 59: 680-683. (Pubitemid 43740010)
5. Sheldon RA, Christen S, Ferriero DM: Genetic and pharmacologic manipulation of oxidative stress after neonatal hypoxia-ischemia. Int J Dev Neurosci 2008; 26: 87-92. (Pubitemid 351192264)
6. Blomgren K, Hagberg H: Free radicals, mitochondria, and hypoxia-ischemia in the developing brain. Free Radic Biol Med 2006; 40: 388-397. (Pubitemid 43139674)
7. Doverhag C, Keller M, Karlsson A, Hedtjarn M, Nilsson U, Kapeller E, Sarkozy G, Klimaschewski L, Humpel C, Hagberg H, Simbruner G, Gressens P, Savman K: Pharma-cological and genetic inhibition of NADPH oxidase does not reduce brain damage in different models of perinatal brain injury in newborn mice. Neurobiol Dis 2008; 31: 133-144. (Pubitemid 351833142)
8. Palmer C, Vannucci RC, Towfighi J: Reduction of perinatal hypoxic-ischemic brain damage with allopurinol. Pediatr Res 1990; 27: 332-336. (Pubitemid 20114005)
9. Palmer C, Towfighi J, Roberts RL, Heitjan DF: Allopurinol administered after inducing hypoxia-ischemia reduces brain injury in 7-day-old rats. Pediatr Res 1993; 33: 405-411. (Pubitemid 23095775)
10. Palmer C, Roberts RL, Bero C: Deferoxamine posttreatment reduces ischemic brain injury in neonatal rats. Stroke 1994; 25: 1039-1045. (Pubitemid 24130313)
11. Bågenholm R, Andiné P, Hagberg H: Effects of the 21-amino steroid tirilazad mesylate (U-74006F) on brain damage and edema after perinatal hypoxia-ischemia in the rat. Pediatr Res 1996; 40: 399-403. (Pubitemid 26282572)
12. Wang X, Svedin P, Nie C, Lapatto R, Zhu C, Gustavsson M, Sandberg M, Karlsson JO, Romero R, Hagberg H, Mallard C: N-acetylcysteine reduces lipopolysaccharide-sensitized hypoxic-ischemic brain injury. Ann Neurol 2007; 61: 263-271. (Pubitemid 46557350)
13. Ikeda T, Xia YX, Kaneko M, Sameshima H, Ikenoue T: Effect of the free radical scavenger, 3-methyl-1-phenyl-2-pyrazolin-5-one (MCI-186), on hypoxia-ischemia-induced brain injury in neonatal rats. Neurosci Lett 2002; 329: 33-36.
14. Noor JI, Ikeda T, Ueda Y, Ikenoue T: A free radical scavenger, edaravone, inhibits lipid peroxidation and the production of nitric oxide in hypoxic-ischemic brain damage of neonatal rats. Am J Obstet Gynecol 2005; 193: 1703-1708. (Pubitemid 41540470)
15. Noor JI, Ikeda T, Mishima K, Aoo N, Ohta S, Egashira N, Iwasaki K, Fujiwara M, Ikenoue T: Short-term administration of a new free radical scavenger, edaravone, is more effective than its long-term administration for the treatment of neonatal hypoxic-ischemic encephalopathy. Stroke 2005; 36: 2468-2474. (Pubitemid 41566979)
16. Noor JI, Ueda Y, Ikeda T, Ikenoue T: Edaravone inhibits lipid peroxidation in neonatal hypoxic-ischemic rats: an in vivo microdialysis study. Neurosci Lett 2007; 414: 5-9. (Pubitemid 46241634)
17. Zhu C, Wang X, Huang Z, Qiu L, Xu F, Vahsen N, Nilsson M, Eriksson PS, Hagberg H, Culmsee C, Plesnila N, Kroemer G, Blomgren K: Apoptosis-inducing factor is a major contributor to neuronal loss induced by neonatal cerebral hypoxia-ischemia. Cell Death Differ 2007; 14: 775-784. (Pubitemid 46444515)
18. Martin LJ, Brambrink A, Koehler RC, Traystman RJ: Primary sensory and forebrain motor systems in the newborn brain are preferentially damaged by hypoxia-ischemia. J Comp Neurol 1997; 377: 262-285. (Pubitemid 27009833)
19. Miller SP, Ramaswamy V, Michelson D, Barkovich AJ, Holshouser B, Wycliffe N, Glidden DV, Deming D, Partridge JC, Wu YW, Ashwal S, Ferriero DM: Patterns of brain injury in term neonatal encephalopathy. J Pediatr 2005; 146: 453-460. (Pubitemid 40469706)
20. Rutherford MA, Azzopardi D, Whitelaw A, Cowan F, Renowden S, Edwards AD, Thoresen M: Mild hypothermia and the distribution of cerebral lesions in neonates with hypoxic-ischemic encephalopathy. Pediatrics 2005; 116: 1001-1006. (Pubitemid 44542834)
21. Martin LJ, Brambrink AM, Price AC, Kaiser A, Agnew DM, Ichord RN, Traystman RJ: Neuronal death in newborn striatum after hypoxia-ischemia is necrosis and evolves with oxidative stress. Neurobiol Dis 2000; 7: 169-191. (Pubitemid 30451032)
22. Mueller-Burke D, Koehler RC, Martin LJ: Rapid NMDA receptor phosphorylation and oxidative stress precede striatal neurodegeneration after hypoxic ischemia in newborn piglets and are attenuated with hypothermia. Int J Dev Neurosci 2008; 26: 67-76. (Pubitemid 351192266)
23. Yang ZJ, Torbey M, Li X, Bernardy J, Golden WC, Martin LJ, Koehler RC: Dopamine receptor modulation of hypoxic-ischemic neuronal injury in striatum of newborn piglets. J Cereb Blood Flow Metab 2007; 27: 1339-1351. (Pubitemid 46985351)
24. Yang ZJ, Carter EL, Torbey MT, Martin LJ, Koehler RC: Sigma receptor ligand 4-phenyl-1-(4-phenylbutyl)-piperidine modulates neuronal nitric oxide synthase/postsynaptic density-95 coupling mechanisms and protects against neonatal ischemic degeneration of striatal neurons. Exp Neurol 2010; 221: 166-174.
25. Yoshida H, Yanai H, Namiki Y, Fukatsu-Sasaki K, Furutani N, Tada N: Neuroprotective effects of edaravone: a novel free radical scavenger in cerebrovascular injury. CNS Drug Rev 2006; 12: 9-20. (Pubitemid 44133577)
26. Edaravone Acute Brain Infarction Study Group: Effect of a novel free radical scavenger, edaravone (MCI-186), on acute brain infarction: randomized, placebo-controlled, double-blind study at multicenters. Cerebrovasc Dis 2003; 15: 222-229.
27. Golden TR, Patel M: Catalytic antioxidants and neurodegeneration. Antioxid Redox Signal 2009; 11: 555-570.
28. Doctrow SR, Huffman K, Marcus CB, Tocco G, Malfroy E, Adinolfi CA, Kruk H, Baker K, Lazarowych N, Mascarenhas J, Malfroy B: Salen-manganese complexes as catalytic scavengers of hydrogen peroxide and cytoprotective agents: structure-activity relationship studies. J Med Chem 2002; 45: 4549-4558.
29. Pong K, Doctrow SR, Baudry M: Prevention of 1-methyl-4-phenylpyridinium- and 6-hydroxydopamine-induced nitration of tyrosine hydroxylase and neurotoxicity by EUK-134, a superoxide dismutase and catalase mimetic, in cultured dopaminergic neurons. Brain Res 2000; 881: 182-189.
30. Pong K, Doctrow SR, Huffman K, Adinolfi CA, Baudry M: Attenuation of staurosporine-induced apoptosis, oxidative stress, and mitochondrial dysfunction by synthetic superoxide dismutase and catalase mimetics, in cultured cortical neurons. Exp Neurol 2001; 171: 84-97. (Pubitemid 32848447)
31. Sharpe MA, Ollosson R, Stewart VC, Clark JB: Oxidation of nitric oxide by oxomanganese-salen complexes: a new mechanism for cellular protection by superoxide dismutase/catalase mimetics. Biochem J 2002; 366: 97-107. (Pubitemid 34971808)
32. Baker K, Marcus CB, Huffman K, Kruk H, Malfroy B, Doctrow SR: Synthetic combined superoxide dismutase/catalase mimetics are protective as a delayed treatment in a rat stroke model: a key role for reactive oxygen species in ischemic brain injury. J Pharmacol Exp Ther 1998; 284: 215-221. (Pubitemid 28109549)
33. Rong Y, Doctrow SR, Tocco G, Baudry M: EUK-134, a synthetic superoxide dismutase and catalase mimetic, prevents oxidative stress and attenuates kainate-induced neuropathology. Proc Natl Acad Sci USA 1999; 96: 9897-9902. (Pubitemid 29398829)
34. Shichinohe H, Kuroda S, Yasuda H, Ishikawa T, Iwai M, Horiuchi M, Iwasaki Y: Neuroprotective effects of the free radical scavenger edaravone (MCI-186) in mice permanent focal brain ischemia. Brain Res 2004; 1029: 200-206. (Pubitemid 39470176)
35. Zhang W, Sato K, Hayashi T, Omori N, Nagano I, Kato S, Horiuchi S, Abe K: Extension of ischemic therapeutic time window by a free radical scavenger, edaravone, reperfused with tPA in rat brain. Neurol Res 2004; 26: 342-348. (Pubitemid 38620058)
36. Agnew DM, Koehler RC, Guerguerian AM, Shaffner DH, Traystman RJ, Martin LJ, Ichord RN: Hypothermia for 24 hours after asphyxic cardiac arrest in piglets provides striatal neuroprotection that is sustained 10 days after rewarming. Pediatr Res 2003; 54: 253-262. (Pubitemid 36918161)
37. Martin LJ, Brambrink AM, Lehmann C, Portera-Cailliau C, Koehler RC, Rothstein J, Traystman RJ: Hypoxia-ischemia causes abnormalities in glutamate transporters and death of astroglia and neurons in newborn striatum. Ann Neurol 1997; 42: 335-348. (Pubitemid 27391117)
38. Johnston MV: Selective vulnerability in the neonatal brain. Ann Neurol 1998; 44: 155-156. (Pubitemid 28374100)
39. Brambrink AM, Martin LJ, Hanley DF, Becker KJ, Koehler RC, Traystman RJ: Effects of the AMPA receptor antagonist NBQX on outcome of newborn pigs after asphyxic cardiac arrest. J Cereb Blood Flow Metab 1999; 19: 927-938. (Pubitemid 30173394)
40. Buonocore G, Groenendaal F: Anti-oxidant strategies. Semin Fetal Neonatal Med 2007; 12: 287-295. (Pubitemid 46875057)
41. Comellas AP, Dada LA, Lecuona E, Pesce LM, Chandel NS, Quesada N, Budinger GR, Strous GJ, Ciechanover A, Sznajder JI: Hypoxia-mediated degradation of Na,KATPase via mitochondrial reactive oxygen species and the ubiquitin-conjugating system. Circ Res 2006; 98: 1314-1322. (Pubitemid 43948087)
42. Samai M, Sharpe MA, Gard PR, Chatterjee PK: Comparison of the effects of the superoxide dismutase mimetics EUK-134 and tempol on paraquat-induced nephrotoxicity. Free Radic Biol Med 2007; 43: 528-534. (Pubitemid 47058233)
43. McLean C, Ferriero D: Mechanisms of hypoxic-ischemic injury in the term infant. Semin Perinatol 2004; 28: 425-432. (Pubitemid 40037569)
44. Martin LJ, Al-Abdulla NA, Brambrink AM, Kirsch JR, Sieber FE, Portera-Cailliau C: Neurodegeneration in excitotoxicity, global cerebral ischemia, and target deprivation: a perspective on the contributions of apoptosis and necrosis. Brain Res Bull 1998; 46: 281-309. (Pubitemid 28294822)
45. Sarco DP, Becker J, Palmer C, Sheldon RA, Ferriero DM: The neuroprotective effect of deferoxamine in the hypoxic-ischemic immature mouse brain. Neurosci Lett 2000; 282: 113-116. (Pubitemid 30129182)
46. Peeters-Scholte C, Braun K, Koster J, Kops N, Blomgren K, Buonocore G, Buul-Offers S, Hagberg H, Nicolay K, van Bel F, Groenendaal F: Effects of allopurinol and deferoxamine on reperfusion injury of the brain in newborn piglets after neonatal hypoxia-ischemia. Pediatr Res 2003; 54: 516-522. (Pubitemid 37159122)
47. Benders MJ, Bos AF, Rademaker CM, Rijken M, Torrance HL, Groenendaal F, van Bel F: Early postnatal allopurinol does not improve short term outcome after severe birth asphyxia. Arch Dis Child Fetal Neonatal Ed 2006; 91:F163-F165. (Pubitemid 43667611)
48. Rosenthal RA, Huffman KD, Fisette LW, Damphousse CA, Callaway WB, Malfroy B, Doctrow SR: Orally available Mn porphyrins with superoxide dismutase and catalase activities. J Biol Inorg Chem 2009; 14: 979-991.
49. Liang LP, Huang J, Fulton R, Day BJ, Patel M: An orally active catalytic metalloporphyrin protects against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity in vivo. J Neurosci 2007; 27: 4326-4333. (Pubitemid 46640723)
50. Schleien CL, Koehler RC, Shaffner DH, Eberle B, Traystman RJ: Blood-brain barrier disruption after cardiopulmonary resuscitation in immature swine. Stroke 1991; 22: 477-483.
51. Mackensen GB, Patel M, Sheng H, Calvi CL, Batinic-Haberle I, Day BJ, Liang LP, Fridovich I, Crapo JD, Pearlstein RD, Warner DS: Neuroprotection from delayed postischemic administration of a metalloporphyrin catalytic antioxidant. J Neurosci 2001; 21: 4582-4592. (Pubitemid 32565617)
52. Sheng H, Yang W, Fukuda S, Tse HM, Paschen W, Johnson K, Batinic-Haberle I, Crapo JD, Pearlstein RD, Piganelli J, Warner DS: Long-term neuroprotection from a potent redox-modulating metalloporphyrin in the rat. Free Radic Biol Med 2009; 47: 917-923.
53. Toyokuni S: Reactive oxygen species-induced molecular damage and its application in pathology. Pathol Int 1999; 49: 91-102. (Pubitemid 29133467)
54. Groenendaal F, Lammers H, Smit D, Nikkels PG: Nitrotyrosine in brain tissue of neonates after perinatal asphyxia. Arch Dis Child Fetal Neonatal Ed 2006; 91:F429-F433. (Pubitemid 44701853)
55. Groenendaal F, Vles J, Lammers H, de Vente J, Smit D, Nikkels PG: Nitrotyrosine in human neonatal spinal cord after perinatal asphyxia. Neonatology 2008; 93: 1-6. (Pubitemid 350277287)